Craft

Gentian Diagnostics

Stock Price

KR50

2021-01-28

Market Capitalization

KR924.2 M

2021-01-28

Revenue

KR176.5 M

FY, 2025

Gentian Diagnostics Summary

Company Summary

Overview
Gentian Diagnostics is a medical diagnostics company, which serves the global market for diagnostic tests with sensitive biochemical products developed by utilizing proprietary, disruptive and diagnostic technologies. The Company develops reagents and methods for clinical laboratories, doctors, and patients.
Type
Public
Status
Active
Founded
2001
HQ
Moss, NO | view all locations
Website
https://gentian.com/
Cybersecurity rating
Sectors

Key People

  • Tomas Settevik, Chairman of the Board

    • Njaal Kind

      Njaal Kind, CFO

      LocationsView all

      4 locations detected

      • Moss, Østfold HQ

        Norway

        Bjørnåsveien 5

      • Orlando, FL

        United States

        215 N Eola Dr

      • Beijing Shi

        China

        Chao Yang Men Wai Da Jie, Chaoyang Qu

      • Stockholm, Stockholms län

        Sweden

        Kungsgatan 8

      Gentian Diagnostics Financials

      Summary Financials

      Revenue (Q1, 2026)
      kr43.9M
      Gross profit (Q1, 2026)
      kr26.0M
      Net income (Q1, 2026)
      (kr20.3M)
      Cash (Q1, 2026)
      kr91.9M
      EBIT (Q1, 2026)
      (kr27.5M)
      Enterprise value
      $850.0M

      Footer menu